Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3T1M

Crystal structure of human galectin-3 carbohydrate recognition domain in complex with methyl 3-deoxy-2-O-toluoyl-3-N-toluoyl-beta-D-talopyranoside

3T1M の概要
エントリーDOI10.2210/pdb3t1m/pdb
関連するPDBエントリー3T1L 3T2T
分子名称Galectin-3, CHLORIDE ION, methyl 3-deoxy-2-O-(4-methylbenzoyl)-3-[(4-methylbenzoyl)amino]-beta-D-talopyranoside, ... (4 entities in total)
機能のキーワードbeta sandwich, sugar binding protein-inhibitor complex, sugar binding protein/inhibitor
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: P17931
タンパク質・核酸の鎖数1
化学式量合計16519.34
構造登録者
Blanchard, H.,Collins, P.M. (登録日: 2011-07-22, 公開日: 2011-12-28, 最終更新日: 2024-03-20)
主引用文献Collins, P.M.,Oberg, C.T.,Leffler, H.,Nilsson, U.J.,Blanchard, H.
Taloside inhibitors of galectin-1 and galectin-3
Chem.Biol.Drug Des., 79:339-346, 2012
Cited by
PubMed Abstract: Galectin-1 and galectin-3 have roles in cancer and inflammation. Galectin-1 has recently emerged as a significant protein produced by tumour cells to promote tumour development, angiogenesis and metastasis and consequently represents an important target to inhibit. The design of inhibitors targeting the carbohydrate recognition domain that is known to recognize galactose is an important approach in the fight against cancer. Based on the analysis of crystal structures, we pursued the concept that if the galactose was replaced with talose (the C2 epimer of galactose) as a scaffold, then O2 substituents would be directed closer to the protein surface and provide opportunity to design inhibitors that are more specific towards particular galectins. Our elucidation of X-ray crystal structures of two of our synthesized talosides in complex with galectin-1 and galectin-3 provides the first atomic information on the interactions of galectins, and indeed any protein, with talosides. These results have enabled a structure-based rationale for the specificity differences shown by galectin-1 and galectin-3 towards these talosides and demonstrate new opportunities for further exploitation as specific inhibitors of galectins.
PubMed: 22136701
DOI: 10.1111/j.1747-0285.2011.01283.x
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.55 Å)
構造検証レポート
Validation report summary of 3t1m
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon